Cargando…

Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia

We explored the feasibility of collecting convalescent plasma for passive immunotherapy of Middle East respiratory syndrome coronavirus (MERS-CoV) infection by using ELISA to screen serum samples from 443 potential plasma donors: 196 patients with suspected or laboratory-confirmed MERS-CoV infection...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arabi, Yaseen M., Hajeer, Ali H., Luke, Thomas, Raviprakash, Kanakatte, Balkhy, Hanan, Johani, Sameera, Al-Dawood, Abdulaziz, Al-Qahtani, Saad, Al-Omari, Awad, Al-Hameed, Fahad, Hayden, Frederick G., Fowler, Robert, Bouchama, Abderrezak, Shindo, Nahoko, Al-Khairy, Khalid, Carson, Gail, Taha, Yusri, Sadat, Musharaf, Alahmadi, Mashail
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994343/ https://www.ncbi.nlm.nih.gov/pubmed/27532807 http://dx.doi.org/10.3201/eid2209.151164

Ejemplares similares

Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
por: Arabi, Yaseen, et al.
Publicado: (2015)

Kinetics of antibody response in critically ill patients with Middle East respiratory syndrome and association with mortality and viral clearance
por: Arabi, Yaseen M, et al.
Publicado: (2021)

MERS-CoV diagnosis: An update
por: Al Johani, Sameera, et al.
Publicado: (2016)

Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians
por: Arabi, Yaseen M., et al.
Publicado: (2016)

Evolving sequence mutations in the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
por: AlBalwi, Mohammed Ali, et al.
Publicado: (2020)

Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)
por: Arabi, Y. M., et al.
Publicado: (2015)

Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection
por: Hajeer, Ali H., et al.
Publicado: (2016)

Unusual rotavirus genotypes among children with acute diarrhea in Saudi Arabia
por: Aly, Mahmoud, et al.
Publicado: (2015)

Leptin, Ghrelin, and Leptin/Ghrelin Ratio in Critically Ill Patients
por: Arabi, Yaseen M., et al.
Publicado: (2019)

Middle East respiratory syndrome coronavirus on inanimate surfaces: A risk for health care transmission
por: Khan, Raymond M., et al.
Publicado: (2016)

Permissive underfeeding, cytokine profiles and outcomes in critically ill patients
por: Arabi, Yaseen, et al.
Publicado: (2019)

The critical care response to a hospital outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: an observational study
por: Al-Dorzi, Hasan M., et al.
Publicado: (2016)

Developing Machine-Learning Prediction Algorithm for Bacteremia in Admitted Patients
por: Mahmoud, Ebrahim, et al.
Publicado: (2021)

A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial
por: Bosaeed, Mohammad, et al.
Publicado: (2020)

Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS)
por: Batawi, Sarah, et al.
Publicado: (2019)

Learning from SARS and MERS: COVID-19 reinfection where do we stand?
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2021)

Critically ill healthcare workers with the middle east respiratory syndrome (MERS): A multicenter study
por: Shalhoub, Sarah, et al.
Publicado: (2018)

Preventing healthcare-associated transmission of the Middle East Respiratory Syndrome (MERS): Our Achilles heel
por: Balkhy, Hanan H., et al.
Publicado: (2016)

Impact of empirical antimicrobial therapy on the outcome of critically ill patients with Acinetobacter bacteremia
por: Al-Dorzi, Hasan M., et al.
Publicado: (2015)

Proceedings of the Middle East Respiratory Syndrome (MERS) Coronavirus research initiative workshop, September 9–10 2015 in Riyadh, KSA
por: Arabi, Yaseen M., et al.
Publicado: (2016)

Differential Gene Expression in Peripheral White Blood Cells with Permissive Underfeeding and Standard Feeding in Critically Ill Patients: A Descriptive Sub-study of the PermiT Randomized Controlled Trial
por: Arabi, Yaseen M., et al.
Publicado: (2018)

Invasive Candidiasis in Critically Ill Patients: A Prospective Cohort Study in Two Tertiary Care Centers
por: Al-Dorzi, Hasan M., et al.
Publicado: (2018)

A pandemic risk assessment of middle east respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia
por: Eifan, Saleh A., et al.
Publicado: (2017)

Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia
por: Al Johani, Sameera M., et al.
Publicado: (2010)

Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial
por: Arabi, Yaseen M., et al.
Publicado: (2018)

Association between β-blocker use and mortality in critically ill patients: a nested cohort study
por: Al Harbi, Shmeylan A., et al.
Publicado: (2018)

The search for therapeutic options for Middle East Respiratory Syndrome (MERS)
por: Arabi, Yaseen M., et al.
Publicado: (2016)

Analysis of the Healthcare MERS-CoV Outbreak in King Abdulaziz Medical Center, Riyadh, Saudi Arabia, June–August 2015 Using a SEIR Ward Transmission Model
por: Oraby, Tamer, et al.
Publicado: (2020)

Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study
por: Al Harbi, Shmeylan A., et al.
Publicado: (2016)

Free Fatty Acids’ Level and Nutrition in Critically Ill Patients and Association with Outcomes: A Prospective Sub-Study of PermiT Trial
por: Arabi, Yaseen M., et al.
Publicado: (2019)

Spatiotemporal Clustering of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Incidence in Saudi Arabia, 2012–2019
por: Al-Ahmadi, Khalid, et al.
Publicado: (2019)

Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective
por: Kanj, Saly, et al.
Publicado: (2021)

Association of compliance of ventilator bundle with incidence of ventilator-associated pneumonia and ventilator utilization among critical patients over 4 years
por: Al-Thaqafy, Majid S., et al.
Publicado: (2014)

Pathogenetic mechanisms of heatstroke and novel therapies
por: Bouchama, Abderrezak
Publicado: (2012)

Emergence of a highly resistant Clostridium difficile strain (NAP/BI/027) in a tertiary care center in Saudi Arabia
por: Alzahrani, Nabeel, et al.
Publicado: (2013)

Management and outcomes of patients presenting with sepsis and septic shock to the emergency department during nursing handover: a retrospective cohort study
por: Alsolamy, Sami, et al.
Publicado: (2018)

MERS coronavirus outbreak: Implications for emerging viral infections
por: Al-Omari, Awad, et al.
Publicado: (2019)

Epidemiology of the first outbreak of carbapenem-resistant Klebsiella pneumoniae in Saudi Arabia
por: Balkhy, HH, et al.
Publicado: (2011)

Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial
por: Bosaeed, Mohammad, et al.
Publicado: (2021)

The journey to zero deep-vein thrombosis in critically ill patients
por: Arabi, Yaseen M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5a4n3kokp6j36630akrpfno755